SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-176417
Filing Date
2024-07-08
Accepted
2024-07-08 18:51:26
Documents
2
Group Members
ARTAL GROUP S.A.ARTAL INTERNATIONAL MANAGEMENT S.A.INVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.MR. AMAURY WITTOUCKSTICHTING ADMINISTRATIEKANTOOR WESTENDWESTEND S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G d574847dsc13g.htm SC 13G 141137
2 EX-99.1 d574847dex991.htm EX-99.1 10359
  Complete submission text file 0001193125-24-176417.txt   153541
Mailing Address VALLEY PARK 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661
Business Address VALLEY PARK 44, RUE DE LA VALLEE LUXEMBOURG N4 L-2661 352224259-1
Artal International S.C.A. (Filed by) CIK: 0001218180 (see all company filings)

IRS No.: 000000000
Type: SC 13G

Mailing Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118 0114318906360
HOOKIPA Pharma Inc. (Subject) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90985 | Film No.: 241106050
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)